З. С. Смирнова

766 total citations
29 papers, 601 citations indexed

About

З. С. Смирнова is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Biomedical Engineering. According to data from OpenAlex, З. С. Смирнова has authored 29 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Biomedical Engineering. Recurrent topics in З. С. Смирнова's work include Nanoplatforms for cancer theranostics (9 papers), Photodynamic Therapy Research Studies (8 papers) and Estrogen and related hormone effects (7 papers). З. С. Смирнова is often cited by papers focused on Nanoplatforms for cancer theranostics (9 papers), Photodynamic Therapy Research Studies (8 papers) and Estrogen and related hormone effects (7 papers). З. С. Смирнова collaborates with scholars based in Russia, United Kingdom and Germany. З. С. Смирнова's co-authors include A. S. Khalansky, Igor Skidan, Svetlana Gelperina, Severin Se, Jörg Kreuter, Sebastian C.J. Steiniger, Martin Kock, Reiner Uhl, Kathrin Geiger and Bernd Turowski and has published in prestigious journals such as International Journal of Cancer, Toxicology Letters and ChemMedChem.

In The Last Decade

З. С. Смирнова

23 papers receiving 563 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
З. С. Смирнова Russia 9 320 222 221 111 85 29 601
Yike Xie China 12 331 1.0× 183 0.8× 261 1.2× 142 1.3× 73 0.9× 18 672
Roberta Dal Magro Italy 13 354 1.1× 206 0.9× 370 1.7× 154 1.4× 46 0.5× 23 792
Puja Panwar Hazari India 17 136 0.4× 139 0.6× 227 1.0× 88 0.8× 72 0.8× 70 826
Nolwenn Lautram France 16 383 1.2× 226 1.0× 359 1.6× 93 0.8× 68 0.8× 34 804
Luojuan Hu Australia 14 317 1.0× 152 0.7× 311 1.4× 158 1.4× 178 2.1× 23 757
Sha Liu China 14 186 0.6× 159 0.7× 315 1.4× 207 1.9× 90 1.1× 39 815
Olga Maksimenko Russia 11 572 1.8× 298 1.3× 292 1.3× 268 2.4× 59 0.7× 16 874
Bajarangprasad L. Pandey India 10 395 1.2× 279 1.3× 269 1.2× 131 1.2× 45 0.5× 11 662
Chunhui Ruan China 14 387 1.2× 381 1.7× 349 1.6× 42 0.4× 102 1.2× 18 806
Telli Hekmatara Germany 6 663 2.1× 316 1.4× 395 1.8× 254 2.3× 99 1.2× 7 1.0k

Countries citing papers authored by З. С. Смирнова

Since Specialization
Citations

This map shows the geographic impact of З. С. Смирнова's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by З. С. Смирнова with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites З. С. Смирнова more than expected).

Fields of papers citing papers by З. С. Смирнова

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by З. С. Смирнова. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by З. С. Смирнова. The network helps show where З. С. Смирнова may publish in the future.

Co-authorship network of co-authors of З. С. Смирнова

This figure shows the co-authorship network connecting the top 25 collaborators of З. С. Смирнова. A scholar is included among the top collaborators of З. С. Смирнова based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with З. С. Смирнова. З. С. Смирнова is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Смирнова, З. С., et al.. (2019). Доклиническое изучение противоопухолевой активности цифетрилина на экспериментальных опухолях животных. Экспериментальная и клиническая фармакология. 82(8). 27–31.
2.
Смирнова, З. С., et al.. (2017). Antiproliferative Activity of a New Nitrosyl Iron Complex with Cysteamine in Human Tumor Cells In Vitro. Bulletin of Experimental Biology and Medicine. 162(4). 583–588. 10 indexed citations
3.
Смирнова, З. С., et al.. (2016). CREATING LABORATORY TECHNOLOGY OF GENERIC EPIRUBICIN PHARMECEUTICAL DOSAGE FORM. Russian Journal of Biotherapy. 15(4). 72–77.
4.
Смирнова, З. С., et al.. (2015). Search for new antitumor compounds among n-glycoside indolo[2,3-a]carbazole derivatives. Russian Journal of Oncology. 20(1). 33–37. 6 indexed citations
5.
Смирнова, З. С., et al.. (2015). PRECLINICAL STUDY OF INDOLOCARBAZOLES N-GLYCOSIDES DERIVATIVE LCS-1208 ANTITUMOR ACTIVITY. REPORT I. Russian Journal of Biotherapy. 14(2). 71–77. 3 indexed citations
6.
Kaluzhny, Dmitry N., et al.. (2015). PRECLINICAL STUDY OF ANTITUMOR ACTIVITY OF INDOLOCARBAZOLES N-GLYCOSIDES DERIVATIVE LCS-1208. REPORT II. Russian Journal of Biotherapy. 14(3). 41–48. 3 indexed citations
7.
Меерович, Г. А., Valentina M. Derkacheva, E. A. LUK'YANETS, et al.. (2015). Near-infrared photosensitizers based on nanostructured forms of phthalocyanine derivatives. Russian Journal of General Chemistry. 85(1). 280–288. 11 indexed citations
9.
Смирнова, З. С., et al.. (2014). Experimental Study of Combined Therapy for Malignant Glioma. Bulletin of Experimental Biology and Medicine. 156(4). 480–482. 4 indexed citations
10.
Смирнова, З. С., et al.. (2013). FLUORESCENCE DIAGNOSIS AND PHOTODYNAMIC THERAPY OF MALIGNANT GLIOMAS IN RATS. Russian Journal of Oncology. 18(2). 14–18.
11.
Kaluzhny, Dmitry N., Victor V. Tatarskiy, Lyubov G. Dezhenkova, et al.. (2009). Novel Antitumor L‐Arabinose Derivative of Indolocarbazole with High Affinity to DNA. ChemMedChem. 4(10). 1641–1648. 13 indexed citations
12.
LUK'YANETS, E. A., Valentina M. Derkacheva, З. С. Смирнова, et al.. (2008). Influence of Liposome Size on Accumulation in Tumor and Therapeutic Efficiency of Liposomal Near-IR Photosensitizer for PDT based on Aluminum hydroxide tetra-3-phenylthiophthalocyanine. TechConnect Briefs. 2(2008). 41–44. 8 indexed citations
13.
Смирнова, З. С., et al.. (2007). Antitumor steroids: 1. Synthesis and biological activity of 11α-hydroxyestra-1,3,5(10)-triene derivatives with bis-(2-chloroethyl)amino-containing substituent at position 3. Pharmaceutical Chemistry Journal. 41(4). 183–187. 2 indexed citations
14.
Смирнова, З. С., et al.. (2005). Hydroxyaluminium Tetra-3-Phenylthiophthalocyanine is a New Effective Photosensitizer for Photodynamic Therapy and Fluorescent Diagnosis. Bulletin of Experimental Biology and Medicine. 139(4). 427–430. 10 indexed citations
15.
Смирнова, З. С., et al.. (2004). Фенилтиозамещенные фталоцианины - новые фотосенсибилизаторы ближнего инфракрасного диапазона. 3(1). 1 indexed citations
16.
Steiniger, Sebastian C.J., Jörg Kreuter, A. S. Khalansky, et al.. (2004). Chemotherapy of glioblastoma in rats using doxorubicin‐loaded nanoparticles. International Journal of Cancer. 109(5). 759–767. 341 indexed citations
17.
Смирнова, З. С., et al.. (2003). Steroidal Nitrates: Synthesis and Antitumor Activity of 9α,11β-Dihydroxyestra-1,3,5(10)-triene 11-Nitrates. Pharmaceutical Chemistry Journal. 37(1). 10–12. 4 indexed citations
18.
Смирнова, З. С., et al.. (2003). Steroid Nitrates. Synthesis and Antitumor Activity of 11‐Nitrates of 9α,11β‐Dihydroxyestra‐1,3,5(10)‐trienes.. ChemInform. 34(23). 1 indexed citations
19.
Gelperina, Svetlana, A. S. Khalansky, Igor Skidan, et al.. (2002). Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma. Toxicology Letters. 126(2). 131–141. 140 indexed citations
20.
Смирнова, З. С., et al.. (2000). Effects of synthetic bis-β-chloroethylamine estrogen derivatives on proliferation of skin sarcoma cells. Bulletin of Experimental Biology and Medicine. 129(6). 592–594. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026